– GEN’s Editor-in-Chief John Sterling interviews Glen Giovannetti, Global Biotechnology Leader, Ernst & Young

Previous articleDelay of Approval for Provenge Sends Dendreon Shares Plunging
Next articlePanacos Extends Medicinal Chemistry Contract with Evotec Into Fourth Year